New Guidelines for Genitourinary Syndrome of Menopause

Timestamps

1. 00:00Introduction
2. 01:35Overview of the 2025 AUA/SUFU Guidelines
3. 02:27Guideline Development Process
4. 05:48Categories of Guidelines
5. 07:03Understanding GSM: Symptoms and Diagnosis
6. 10:28Patient Education and Shared Decision Making
7. 15:22Hormonal Interventions and Safety Concerns
8. 17:17Local Vaginal Estrogen: Recommendations and Usage
9. 23:12Compounded Estrogens and Alternative Therapies
10. 25:48Understanding Estrogen Dosage Forms
11. 26:11Introduction to DHEA and Its Benefits
12. 27:15Exploring Ospemifene as an Alternative
13. 28:05Guidelines for Treating GSM Symptoms
14. 30:11The Role of Vaginal Estrogen in UTI Prevention
15. 33:01Non-Hormonal Interventions for GSM
16. 35:39Laser Treatments for GSM
17. 39:59Addressing Cancer Risks with Vaginal Estrogen
18. 44:48Endometrial Surveillance and Follow-Up
19. 49:14Advocating for Vaginal Estrogen Use
20. 51:13Conclusion and Final Thoughts

More about this episode

The doctors delve into what GSM is, its symptoms, and the new evidence-based clinical guidelines for screening, diagnosing, and treating this condition. The episode emphasizes shared decision-making, safe use of local low-dose vaginal estrogen, and addresses concerns related to hormone therapy and cancer risks. Additionally, the doctors cover non-hormonal interventions, the role of vaginal moisturizers and lubricants, and the use of vaginal lasers. The importance of follow-up and ongoing patient education is also highlighted. The conversation aims to equip clinicians with the knowledge to better manage GSM and improve patient outcomes.